top of page

Publications

29 Jul 2026

Preclinical characterization of FAP-targeting radioconjugates: assessing biophysical and pharmacokinetic equivalence of lutetium-177 and terbium-161

Ana Katrina Mapanao, Ecem Selin Adakli, Christian Vaccarin, Fan Sozzi-Guo, Anzhelika N. Moiseeva, Roger Schibli, Nicholas P. van der Meulen, Cristina Müller & Thera4Care Consortium

9 Sept 2025

The molecular blueprint of targeted radionuclide therapy

Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout & Ken Herrmann.

25 Apr 2025

Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis

Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini & Angela Collarino

bottom of page